Skip to main content
Metin Ozdemirli, MD, Pathology, Washington, DC

Metin Ozdemirli MD

Hematopathology, Anatomic Pathology, Clinical Pathology


Professor, Pathology, Georgetown University Hospital

Join to View Full Profile
  • 3800 Reservoir Rd NwWashington, DC 20007

  • Phone+1 202-444-3614

Are you Dr. Ozdemirli?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Metin Ozdemirli, MD is a board certified pathologist in Washington, District of Columbia. He is currently licensed to practice medicine in District of Columbia and Maryland. He is a Professor at Georgetown University Hospital.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1992 - 1995
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1993

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1995 - 2027
  • MD State Medical License
    MD State Medical License 2023 - 2025
  • Anatomic Pathology
    American Board of Pathology Anatomic Pathology
  • Hematology
    American Board of Pathology Hematology

Publications & Presentations

PubMed

Press Mentions

  • Case Study Reveals Important New Details About Rare Second Cancers Related to CAR-T Therapy
    Case Study Reveals Important New Details About Rare Second Cancers Related to CAR-T TherapyJune 13th, 2024
  • Tragic New Details About Dozens of American Patients Whose Life-Saving Cancer Treatment Caused Them to Develop More Cancers
    Tragic New Details About Dozens of American Patients Whose Life-Saving Cancer Treatment Caused Them to Develop More CancersJune 13th, 2024
  • Immunotherapy to Treat Cancer Gave Rise to 2nd Cancer in Extremely Rare Case
    Immunotherapy to Treat Cancer Gave Rise to 2nd Cancer in Extremely Rare CaseJune 14th, 2024
  • Join now to see all